Perspectives from the Society for Pediatric Research: interventions targeting social needs in pediatric clinical care

Andrew F Beck1,2, Alicia J Cohen3,4, Jeffrey D Colvin3,5

  • 1Department of Pediatrics, University of Cincinnati College of Medicine; Division of General & Community Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. Andrew.Beck1@cchmc.org.

Pediatric Research
|May 26, 2018
PubMed

Insights

Social determinants of health impact pediatric health outcomes. This review covers clinical interventions addressing social needs like food and housing insecurity, and challenges in evaluating them.

Area of Science:

  • Pediatric health
  • Social determinants of health (SDoH)
  • Health outcomes

Background:

  • SDoH encompass conditions affecting health from birth through aging.
  • Childhood social issues are linked to adult diseases like diabetes and hypertension.
  • Mechanisms include access to care, environmental exposures, behaviors, and toxic stress.

Purpose of the Study:

  • Review pediatric clinical interventions addressing SDoH.
  • Examine interventions for food insecurity, housing insecurity, and access to care.
  • Summarize challenges in evaluating these social needs interventions.

Main Methods:

  • Literature review of pediatric-focused clinical interventions.
  • Analysis of studies on basic needs interventions.
  • Synthesis of common evaluation challenges.

Main Results:

  • Evidence supports pediatric interventions for SDoH.
  • Interventions target critical needs like food and housing.
  • Evaluation of social needs interventions faces common hurdles.

Conclusions:

  • Social needs interventions are crucial in pediatrics.
  • Value-based care models incentivize SDoH interventions.
  • Future research should explore new inquiry opportunities.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
274
Social Cognitive Perspective on Personality01:30

Social Cognitive Perspective on Personality

Social cognitive perspectives on personality emphasize the importance of conscious awareness, beliefs, expectations, and goals in shaping behavior. These perspectives incorporate behaviorist principles, such as learning through reinforcement and conditioning, but extend beyond them by highlighting human reasoning and planning. Unlike traditional behaviorist views, social cognitive theory focuses on how individuals reflect on their past experiences and plan for future outcomes by considering...
1.0K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
326
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
242
Changes in Skin Color: Clinical Perspectives01:14

Changes in Skin Color: Clinical Perspectives

The first thing a clinician sees is the skin, so the examination of the skin should be part of any thorough physical examination. Most skin disorders are relatively benign, but a few, including melanomas, can be fatal if untreated. A couple of the more noticeable disorders, albinism and vitiligo, affect the appearance of the skin and its accessory organs.
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
3.7K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305